louisayuen – HKAPI

26 3 月 26

HKAPI AGM and Formation of the New Board

We are pleased to announce the formation of the HKAPI’s new Board (2026-28) following our Annual General Meeting on 26 March 2026.

09 3 月 26

醫藥法規趨勢分享會

HKAPI Regulatory Affairs Working Group (RAWG) hosted a "Regulatory Intelligence Sharing" session on 9 March 2026.

29 1 月 26

2026 粵港澳大灣區真實世界研究論壇

本會與粵港澳大灣區國際臨床試驗所及其主要設施真實世界研究及應用中心合辦的「2026 粵港澳大灣區真實世界研究論壇」，匯聚來自海外、中國內地及大灣區（包括香港）的政府代表、學術界權威、醫療機構代表及藥業界領袖等，共同探討真實世界研究如何推動未來醫療發展。

06 12 月 25

2025 港澳醫療領域發展論壇——共建醫藥發展生態圈

港澳醫療領域發展論壇以「共建醫藥發展生態圈」為主題，於2025年12月6日假澳門大學校園舉行，為新冠疫情後首度復辦。

10 7 月 25

醫藥法規簡介會：香港藥械監管中心及「1+」藥物審批機制

To help members understand the latest policy, the HKAPI Regulatory Affairs Working Group held a workshop on July 10, 2025, focusing on the CMPR's strategic plan and the "1+" mechanism.

12 2 月 25

Visiting GBAICTI: Paving the Way for Cross-Boundary Clinical Trials

On 12 February 2025, around 30 delegates from 20 member companies visited GBAICTI and HTCZ.

27 1 月 25

Welcome Bloomberg as HKAPI’s Catalyst Member

We are delighted to welcome Bloomberg as a Catalyst Member of the Hong Kong Association of the Pharmaceutical Industry (HKAPI).

22 10 月 24

粵港澳大灣區聯會真實世界研究論壇

香港科研製藥聯會及中國外商投資企業協會藥品研製和開發工作委員會（RDPAC）合辦「2024年粵港澳大灣區聯會真實世界研究論壇」，旨在共建有利於真研發展的環境。